KC-1451
Epidermal growth factor receptor (EGFR), also known as HER1 or ERBB1, is a transmembrane receptor tyrosine kinase of the ERBB family. It is expressed on epithelial cells and, upon binding epidermal growth factor, activates RAS-RAF-MEK-ERK and PI3K-AKT signaling that drives proliferation, survival and migration. EGFR is frequently overexpressed or mutated in carcinomas including non-small-cell lung cancer, colorectal cancer and head and neck cancer, and it is a validated target of tyrosine kinase inhibitors and of therapeutic antibodies such as cetuximab and panitumumab.
| Catalog Number | KC-1451 |
|---|---|
| Cell Line Name | CT26-EGFR Cell Line |
| NCBI/UniProt Accession Number | NM_005228 |
| Clone Number | 2-5# |
| Host Cell Line | CT26 |
| Description | The CT26-EGFR cell line stably overexpresses human EGFR on a murine colon carcinoma background |
| Quantity | One vial of frozen cells (≥2×106 cells) |
| Stability | Stable in culture over a minimum of 10 passages |
| Application | Drug screening and biological assays |
| Freezing Medium | 70% RPMI1640+20%FBS+10%DMSO |
| Propagation Medium | RPMI1640+10%FBS+10µg/mL Puromycin |
| Selection Marker | Puromycin |
| Morphology | Epithelial-like |
| Subculture | Split at a ratio of 1:4–1:8 every 2–3 days |
| Incubation | 37 °C with 5% CO2 |
| Storage | Liquid nitrogen immediately upon receiving |
| Doubling Time | Estimated 28 hours |
| Mycoplasma Status | Negative |
| In Vivo Validation | NA |